BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Human epidermal growth factor receptor 2
1
Emergence of human epidermal growth factor receptor 2 as key biomarker and therapeutic target in advanced urothelial carcinoma
7/24/2026 6:11:15 AM | Browse: 27 | Download: 41
2
Advancing precision medicine in human epidermal growth factor receptor 2 negative gastric cancer: Insights from a novel nomogram for immunochemotherapy prognosis
2/3/2026 6:28:03 AM | Browse: 124 | Download: 262
3
Colorectal cancer metastasis to the brain: A scoping review of incidence, treatment, and outcomes
12/22/2025 7:43:01 AM | Browse: 234 | Download: 362
4
Perioperative immunotherapy combined with standard therapy for human epidermal growth factor receptor 2-positive locally advanced gastric cancer: A case report
11/21/2025 7:06:13 AM | Browse: 257 | Download: 546
5
Human epidermal growth factor receptor 2 overexpression is associated with high-grade tumors in upper tract urothelial carcinoma
10/24/2025 6:10:15 AM | Browse: 83 | Download: 302
6
Deciphering prognostic markers in gastric signet ring cell carcinoma: Human epidermal growth factor receptor 2 and other key factors
8/20/2025 8:41:26 AM | Browse: 346 | Download: 947
7
Precision treatment for human epidermal growth factor receptor 2-amplified advanced rectal cancer: A case report
3/25/2025 4:19:10 PM | Browse: 189 | Download: 874
8
Efficacy of disitamab vedotin-containing therapy in metastatic colorectal cancer: A case report
1/21/2025 9:22:13 AM | Browse: 264 | Download: 855
9
BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer
10/25/2024 10:27:30 AM | Browse: 165 | Download: 934
10
Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer
6/15/2024 2:49:03 AM | Browse: 246 | Download: 953
11
Human epidermal growth factor receptor 2 expression level and combined positive score can evaluate efficacy of advanced gastric cancer
5/21/2024 7:25:52 AM | Browse: 136 | Download: 952
12
PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report
3/6/2024 6:10:52 AM | Browse: 410 | Download: 1061
13
Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives
10/22/2021 9:56:10 AM | Browse: 752 | Download: 1496
14
HER2-positive adenocarcinoma arising from heterotopic pancreas tissue in the duodenum: A case report
7/26/2021 11:20:59 AM | Browse: 908 | Download: 2199
15
Response of human epidermal growth factor receptor 2-positive colorectal cancer to lapatinib monotherapy: A case report
9/10/2020 5:57:28 AM | Browse: 1078 | Download: 2447
16
HER2 heterogeneity is a poor prognosticator for HER2 positive gastric cancer
8/6/2019 11:50:46 AM | Browse: 1516 | Download: 2329
17
Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
4/15/2019 10:50:47 AM | Browse: 1363 | Download: 2900
18
Formalin fixation on HER-2 and PD-L1 expression in gastric cancer: A pilot analysis using the same surgical specimens with different fixation times
2/26/2019 9:05:11 AM | Browse: 1184 | Download: 2528
19
Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status
9/28/2018 10:31:14 AM | Browse: 1209 | Download: 2308
20
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer
7/15/2018 9:50:44 AM | Browse: 1419 | Download: 1880
21
Targeted therapies in breast cancer: New challenges to fight against resistance
4/7/2017 8:24:12 AM | Browse: 1462 | Download: 2589
22
Recent developments and innovations in gastric cancer
4/29/2016 4:50:00 PM | Browse: 1989 | Download: 2939
23
Companion diagnostics for the targeted therapy of gastric cancer
12/10/2015 10:17:00 AM | Browse: 1188 | Download: 2080
24
Human epidermal growth factor receptor 2 amplification and protein expression in mixed gastric carcinoma
4/30/2015 2:11:00 PM | Browse: 1265 | Download: 2486
25
Recent advances in the HER2 targeted therapy of gastric cancer
1/14/2015 10:56:00 AM | Browse: 1571 | Download: 1855
26
Targeted approaches for HER2 breast cancer therapy: News from nanomedicine?
12/12/2014 11:15:00 AM | Browse: 1425 | Download: 1881
27
Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer
9/16/2014 1:19:00 PM | Browse: 1422 | Download: 1180
28
HER2 therapies and gastric cancer: A step forward
9/12/2014 8:40:00 PM | Browse: 1336 | Download: 1325
29
Personalizing therapies for gastric cancer: Molecular mechanisms and novel targeted therapies
9/12/2014 8:40:00 PM | Browse: 1375 | Download: 1364
30
Death decoy receptor overexpression and increased malignancy risk in colorectal cancer
8/29/2014 11:31:00 AM | Browse: 1141 | Download: 1560
31
Role of human epidermal growth factor receptor 2 in gastric cancer: Biological and pharmacological aspects
8/28/2014 5:50:00 PM | Browse: 1619 | Download: 1585